Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Allergy Clin Immunol ; 122(4): 803-810, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18760454

RESUMO

BACKGROUND: Mobilization of hemopoietic progenitor cells from the bone marrow (BM) is a feature of inflammatory asthmatic responses. Understanding the mechanisms regulating progenitor cell mobilization and trafficking to the peripheral circulation might be important for the development of effective asthma therapies. OBJECTIVE: We investigated the role of adhesion molecules in the mobilization of hemopoietic progenitor cells from the BM during an allergen-induced asthmatic response. METHODS: BM and peripheral blood samples were obtained from dual-responders with mild asthma before and at several time points after allergen challenge. Fluctuations in expression and adhesive properties of beta1- and beta2-integrins on CD34(+)CD45(+) progenitor cells were assessed by using flow cytometry and adhesion to protein-coated wells, respectively. RESULTS: On BM-derived CD34(+)CD45(+) cells, expression of very late antigen (VLA) 4, but not VLA-5 or Mac-1, decreased significantly 24 hours after allergen challenge and had begun to recover by 48 hours after challenge. In peripheral blood allergen challenge induced a significant decrease in VLA-4 levels after 6 hours, which had not recovered by 96 hours after challenge. Similarly, VLA-5 expression decreased, most prominently at 72 to 96 hours after allergen challenge. In contrast, Mac-1 levels did not change. Chemokine-stimulated adhesion of BM-derived CD34(+)CD45(+) cells to fibronectin was significantly attenuated 24 hours after challenge. Furthermore, adhesion to fibronectin and vascular cell adhesion molecule 1 was greatly reduced by anti-VLA-4 or anti-VLA-5 antibodies. CONCLUSIONS: Preferential downregulation of beta1-integrin expression on progenitor cells can reduce the tethering forces to BM components, thus facilitating their egress to the peripheral circulation during an allergic inflammatory response.


Assuntos
Alérgenos/farmacologia , Asma/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Células-Tronco Hematopoéticas/metabolismo , Integrina beta1/biossíntese , Adolescente , Adulto , Alérgenos/imunologia , Antígenos CD34/imunologia , Antígenos CD34/metabolismo , Asma/imunologia , Medula Óssea/imunologia , Medula Óssea/metabolismo , Antígenos CD18/biossíntese , Antígenos CD18/imunologia , Adesão Celular/efeitos dos fármacos , Adesão Celular/imunologia , Células Cultivadas , Quimiocinas/imunologia , Quimiocinas/metabolismo , Quimiocinas/farmacologia , Feminino , Fibronectinas/imunologia , Fibronectinas/metabolismo , Regulação da Expressão Gênica/imunologia , Mobilização de Células-Tronco Hematopoéticas , Células-Tronco Hematopoéticas/imunologia , Humanos , Inflamação/imunologia , Inflamação/metabolismo , Integrina alfa4beta1/imunologia , Integrina alfa4beta1/metabolismo , Integrina alfa5beta1/imunologia , Integrina alfa5beta1/metabolismo , Integrina beta1/imunologia , Antígenos Comuns de Leucócito/imunologia , Antígenos Comuns de Leucócito/metabolismo , Antígeno de Macrófago 1/imunologia , Antígeno de Macrófago 1/metabolismo , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA